Strategies for in Silico Drug Discovery to Modulate Macromolecular Interactions Altered by Mutations

Area of Science:

• Biochemistry
• Genetics
• Pharmacology

Background:

• Many human diseases stem from genetic variations, particularly single nucleotide variants (SNVs), which disrupt normal macromolecular functions.
• Altered protein-protein or protein-nucleic acid interactions are implicated in various disorders, including Snyder-Robinson syndrome and cancer.
• Pathogenic mutations can directly change binding affinities or indirectly affect partner concentrations, leading to disease.

Purpose of the Study:

• To review computational methods for identifying small molecules that modulate macromolecular interactions.
• To outline strategies for designing small molecules that can correct disease-causing alterations in binding affinity and specificity.
• To provide examples of successful applications of these computational strategies.

Main Methods:

• Computational identification of small molecules targeting macromolecular interactions.
• Strategies for designing molecules to restore wild type binding affinities.
• Analysis of direct and indirect effects of mutations on molecular interactions.

Main Results:

• Progress in computational methods for identifying small molecules that alter macromolecular interactions.
• Demonstration of strategies to reduce or increase binding affinity therapeutically.
• Examples of successful applications in correcting disease-related molecular dysfunctions.

Conclusions:

• Computational approaches are effective in discovering small molecules to correct genetic disease mechanisms.
• Targeting macromolecular interactions with small molecules offers a promising therapeutic avenue.
• Further development of these computational strategies can advance precision medicine for genetic disorders.